Condition

Advanced Malignant Solid Tumors clinical trials and research

• 11Clinical trials
• 2Countries

Newest Advanced Malignant Solid Tumors clinical trials

All recruiting trials (11)

• HEC-921 Injection in adults with advanced solid tumors

  A first-in-human trial tests HEC-921 alone and with other cancer drugs to see how safe it is and how the body handles it in adults with advanced solid tumors.

  Recruiting Phase 1 Sunshine Lake Pharma Co., Ltd. · Shanghai · NCT07824934

• N-3C01 as a standalone treatment and with PD-(L)1 inhibitor in advanced solid tumors

  This study tests N-3C01 alone and with a PD-(L)1 inhibitor to see if it is safe and helps people with advanced solid tumors.

  Recruiting Phase 1/2 Hefei Xinzhu Biological Technology Co., Ltd. · Saint Leonards, New South Wales and 5 other locations · NCT07639450

• First-in-human test of JSKN021 in advanced solid tumors

  This phase 1 study will test the safety and basic activity of JSKN021 in adults with advanced solid tumors who have exhausted standard treatments.

  Recruiting at 10 sites Phase 1 Jiangsu Alphamab Biopharmaceuticals Co., Ltd · Fuzhou, Fujian and 9 other locations · NCT07617727

• JS212 and JS213 alone and in combination for advanced solid tumors

  This trial will test whether JS212 and JS213, given alone or combined with each other or with JS207 or toripalimab, can shrink tumors in people with advanced solid tumors who have progressed after standard treatments.

  Recruiting Phase 2 Shanghai Junshi Bioscience Co., Ltd. · Beijing, Beijing Municipality · NCT07480733

• TPD3310 in patients with advanced malignant solid tumors

  This first-in-human study tests TPD3310 in adults with advanced solid tumors to see if it is safe, tolerable, and shows any signs of activity.

  Recruiting Phase 1 Taibidi Pharmaceutical Technology(shijiazhuang) Co.,ltd. · Beijing, Beijing Municipality · NCT07368127

• JSKN022 for advanced malignant solid tumors

  This will test whether JSKN022 is safe and tolerable for adults with advanced unresectable or metastatic epithelial solid tumors who have exhausted or cannot receive standard treatments.

  Recruiting Phase 1 Jiangsu Alphamab Biopharmaceuticals Co., Ltd · Guangzhou, Guangdong · NCT07292402

• CD70-targeted CAR-NKT cell therapy for advanced solid tumors

  This study is testing a new treatment using modified immune cells to see if it can help people with advanced solid tumors that have a specific marker called CD70.

  Recruiting Phase 1 Peking University Cancer Hospital & Institute · Beijing · NCT06728189

• Testing CSCJC3456 in patients with advanced malignant tumors

  This study is testing a new medication called CSCJC3456 in people with advanced solid tumors to see how safe it is and if it can help them.

  Recruiting at 2 sites Phase 1 Changshan ConjuChem BioPharmaceutical Research and Development (Hebei) Co., Ltd. · Beijing, Beijing Municipality and 1 other locations · NCT06717750

• FC084CSA combined with tislelizumab for advanced solid tumors

  This trial tests whether adding the experimental drug FC084CSA to the immunotherapy tislelizumab helps adults (18–75) with advanced solid tumors that have progressed after standard treatments.

  Recruiting Phase 1/2 FindCure Biosciences (ZhongShan) Co., Ltd. · Shanghai, Shanghai Municipality · NCT06499350

• Evaluating GQ1010 for Advanced Solid Tumors

  This study is testing a new treatment called GQ1010 to see if it is safe and effective for people with advanced solid tumors.

  Recruiting at 5 sites Phase 1/2 GeneQuantum Healthcare (Suzhou) Co., Ltd. · Beijing and 4 other locations · NCT06464055

• Personalized neoantigen vaccine treatment for advanced solid tumors

  This study is testing a personalized vaccine treatment for people with advanced solid tumors to see if it can help their immune system fight the cancer better.

  Recruiting The First Affiliated Hospital of Nanchang University · Nanchang, Jiangxi · NCT05749627

Related topics

Quick answers

How many Advanced Malignant Solid Tumors clinical trials are recruiting right now?

11, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 2 countries. The most sites are in China (11 trials), Australia (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 1: 6, Phase 1/2: 3, Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →